How do earnout provisions work in pharma licensing deals?

Licensing deals typically include an upfront payment (10-30% of total deal value), development milestones tied to IND filing, Phase 2/3 initiation, and regulatory approval, plus commercial milestones and tiered royalties on net sales (typically 10-25% depending on originator involvement).